Journal
Nephrology, dialysis, transplantation
Publication Date
8-1-2025
Volume
40
Issue
8
First Page
1559
Last Page
1569
Document Type
Open Access Publication
DOI
10.1093/ndt/gfaf022
Rights and Permissions
Rajiv Agarwal, Jennifer B Green, Hiddo J L Heerspink, Johannes F E Mann, Janet B McGill, Amy K Mottl, Julio Rosenstock, Peter Rossing, Muthiah Vaduganathan, Meike Brinker, Robert Edfors, Na Li, Markus F Scheerer, Charlie Scott, Masaomi Nangaku, for the CONFIDENCE investigators , COmbinatioN effect of FInerenone anD EmpaglifloziN in participants with chronic kidney disease and type 2 diabetes using a UACR Endpoint (CONFIDENCE) trial: baseline clinical characteristics, Nephrology Dialysis Transplantation, Volume 40, Issue 8, August 2025, Pages 1559–1569, https://doi.org/10.1093/ndt/gfaf022. https://academic.oup.com/ndt/article/40/8/1559/7997692?login=true. © The Author(s) 2025. Published by Oxford University Press on behalf of the ERA. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
Recommended Citation
Agarwal, Rajiv; McGill, Janet B; and et al., "COmbinatioN effect of FInerenone anD EmpaglifloziN in participants with chronic kidney disease and type 2 diabetes using a UACR Endpoint (CONFIDENCE) trial: Baseline clinical characteristics." Nephrology, dialysis, transplantation. 40, 8. 1559 - 1569. (2025).
https://digitalcommons.wustl.edu/oa_4/5545
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
